## Abstract The blood‐brain barrier (BBB) regulates the passage of molecules between the bloodstream and the brain. Overcoming the difficulty of delivery drugs to specific areas of the brain is a major challenge. The BBB exerts a neuroprotective function as it hinders the delivery of diagnostic and
Delivery of chemotherapy and antibodies across the blood–brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the eleventh annual blood–brain barrier consortium meeting
✍ Scribed by Nancy D. Doolittle; David M. Peereboom; Gregory A. Christoforidis; Walter A. Hall; Diane Palmieri; Penelope R. Brock; Kathleen C. M. Campbell; D. Thomas Dickey; Leslie L. Muldoon; Brian Patrick O’Neill; Darryl R. Peterson; Brad Pollock; Carole Soussain; Quentin Smith; Rose Marie Tyson; Edward A. Neuwelt
- Publisher
- Springer US
- Year
- 2006
- Tongue
- English
- Weight
- 230 KB
- Volume
- 81
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Pericytes are a very important cellular constituent of the blood-brain barrier. They play a regulatory role in brain angiogenesis, endothelial cell tight junction formation, blood-brain barrier differentiation, as well as contribute to the microvascular vasodynamic capacity and structural stability.
## Abstract ## BACKGROUND. Cerebral metastases are clinically significant in 10% to 30% of patients with neoplasia. Multiple cerebral metastases are typically treated with palliative radiotherapy. There is no consensus on the role of enhanced chemotherapy delivery as an adjuvant treatment modality
## Abstract The permeability of the blood brain barrier (BBB) to β‐hydroxybutyrate (β‐HB) was computed in fed and starved (five days) rats by the simultaneous measurement of cerebral blood flow (diffusible indicator method‐^123^I‐iodoantipyrine) and brain uptake of ^14^C‐β‐HB (relative to a ^3^H~2~
W e previously demonstrated that brain microvessels have a high density of the erythrocyte-type glucose transporter and suggested this could be used as a marker of cells with "occluding" junctions. Now, we have studied by immunocytochemistry the tissue distribution of the glucose transporter in a va